{"id":45546,"date":"2022-06-27T17:02:01","date_gmt":"2022-06-27T15:02:01","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/cancer-vaccines-analytical-tool-2022-a-must-have-for-any-business-developer-bi-ci-operative-or-clinical-developer-who-needs-to-be-on-top-of-this-hot-and-fast-moving-area-of-immune-oncology-researc\/"},"modified":"2022-06-27T17:02:01","modified_gmt":"2022-06-27T15:02:01","slug":"cancer-vaccines-analytical-tool-2022-a-must-have-for-any-business-developer-bi-ci-operative-or-clinical-developer-who-needs-to-be-on-top-of-this-hot-and-fast-moving-area-of-immune-oncology-researc","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/cancer-vaccines-analytical-tool-2022-a-must-have-for-any-business-developer-bi-ci-operative-or-clinical-developer-who-needs-to-be-on-top-of-this-hot-and-fast-moving-area-of-immune-oncology-researc\/","title":{"rendered":"Cancer Vaccines Analytical Tool 2022: A Must-have for Any Business Developer, BI\/CI Operative or Clinical Developer who Needs to be on Top of this Hot and Fast Moving Area of Immune-Oncology &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/1196672\/cancer_vaccines_analytical_tool?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=jjg8mg&amp;utm_campaign=1719080+-+Cancer+Vaccines+Analytical+Tool+2022%3A+A+Must-have+for+Any+Business+Developer%2C+BI%2FCI+Operative+or+Clinical+Developer+who+Needs+to+be+on+Top+of+this+Hot+and+Fast+Moving+Area+of+Immune-Oncology&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Cancer Vaccines: Analytical Tool&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220627005557\/en\/1497799\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220627005557\/en\/1497799\/21\/logo.jpg\"><\/a><\/p>\n<p>\nCancer Vaccines: Analytical Tool is the must have handbook for any business developer, BI\/CI operative or clinical developer who needs to be on top of this hot and fast moving area of immune-oncology.\n<\/p>\n<p>\nThis unique product is truly the only tool of its kind and is designed to give you a competitive edge in your cancer vaccine drug surveillance and intelligence, allowing you to power your decision making and advance your own interests.\n<\/p>\n<p>\nYour Cancer Vaccines: Analytical Tool covers more than 372 companies plus partners who are today developing 767 cancer vaccine drugs where of 482 are in active development in cancer across 211 different targets.\n<\/p>\n<p>\nAny data and\/or analysis from the Analytical Tool is yours to keep and data\/graphs\/tables can be easily exported into Excel\/PDF and various graphic formats for mixing with your own proprietary information.\n<\/p>\n<p>\n<strong>Keeping you &#8220;In the know&#8221;<\/strong>\n<\/p>\n<p>\nSimply put, our mission is to fuel your knowledge of immune-oncology, to make you the first to know about very early technologies and startups, emerging clinical trial results, drug approvals and the ever-changing competitive landscape.\n<\/p>\n<p>\n<strong>Cancer Vaccines: Analytical Tool achieves this by continuously scanning development in cancer vaccine and reporting:<\/strong>\n<\/p>\n<ul>\n<li>\nDeals &amp; Collaborations\n<\/li>\n<li>\nNew technologies\/drugs (emerging from patents, grants, abstracts (see Conference Coverage) etc.)\n<\/li>\n<li>\nFunding\/Grants\/IPOs\n<\/li>\n<li>\nFilings &amp; Approvals\n<\/li>\n<li>\nLatest Clinical Trial Development &amp; Results\n<\/li>\n<li>\nNewly launched clinical trials\n<\/li>\n<li>\nConference Coverage of the world&#8217;s twelve leading meetings in oncology*\n<\/li>\n<li>\nQuarterly &amp; Annual Reporting\n<\/li>\n<\/ul>\n<p>\nThis puts you in control of most, if not all, day-to-day developments in your field while also benefiting from one of the most comprehensive commercial pipeline review &amp; competitive assessment tools available on the market today!\n<\/p>\n<p>\n<strong>Identify, prioritize, and lead scientific assessment of oncology opportunities and competition by multiple factors such as:<\/strong>\n<\/p>\n<ul>\n<li>\nEmerging Technologies\n<\/li>\n<li>\nTarget Novelty\n<\/li>\n<li>\nRecent Funding\n<\/li>\n<li>\nEarly &amp; Late Stage Pipeline\n<\/li>\n<li>\nBiomarker\/Companion Diagnostic Development (featured below)\n<\/li>\n<li>\nEntered Deals &amp; Alliances\n<\/li>\n<li>\nConference surveillance of world leading cancer meetings (featured below)\n<\/li>\n<li>\nCombination Therapy Choices (featured below)\n<\/li>\n<li>\nOutcome of Clinical Trials\n<\/li>\n<li>\nIndication Selection &amp; Expansion Choices\n<\/li>\n<li>\nDrug Repositioning Opportunities\n<\/li>\n<\/ul>\n<p>\n<strong>Let our expertise work for you<\/strong>\n<\/p>\n<p>\nWith a simple point and click interface you can navigate the environment of current development, drill down into specific areas such as ongoing combination trials, biomarker analysis, selected scientific abstracts etc. and generate drug profiles, drug target profiles and company profiles (including Business Development &amp; Licensing contacts). Any analysis generated by you is packed with presentation-ready graphs and tables to use in your reports and presentations.\n<\/p>\n<p>\n<strong>Your key to access development at the world-leading cancer meetings<\/strong>\n<\/p>\n<p>\nThe Cancer Vaccines: Analytical Tool is continuously updated according to twelve of the world&#8217;s most influential meetings in oncology (AACR, ASCO, ASGCT, ASH, CMIT, EHA, EORTC-NCI-AACR, ESMO, SITC and BIO (International, Europe and Asia). If you are not able to attend any of the conference(s) in person, this Analytical Tool ensures that you are not missing out on the important take home messages you need to know about.\n<\/p>\n<p>\n<strong>Run combination therapy analysis like no other<\/strong>\n<\/p>\n<p>\nThe Cancer Vaccines: Analytical Tool delivers comprehensive combination therapy analysis, allowing you to analyze combination therapies from multiple perspectives; from a single drug to virtually any cross section of oncology drugs of interest.\n<\/p>\n<p>\n<strong>Unparalleled biomarker surveillance<\/strong>\n<\/p>\n<p>\nWe also provide an outstanding oncology clinical biomarker surveillance &amp; analysis, highlighting clinical phenotyping and patient stratification in trials. This analysis is based on our monitoring of the presence and usage of more than 1,000 biomarkers across tens of thousands of cancer clinical trials.\n<\/p>\n<p>\n<strong>Support and inspiration at your finger-tips<\/strong>\n<\/p>\n<p>\nYou also have access to a great selection of How-to Training Videos showing best practice approaches to aspects such as competitive pipeline analysis right through to many real world case examples put forward by other users of our Analytical Tools.\n<\/p>\n<p>\n<strong>A tool to grow with and keep you informed<\/strong>\n<\/p>\n<p>\nUnlike a static report which just represents a particular snapshot in time, all of the Analytical Tools come with one year of online access to twice-weekly updates in both contents and features, pipeline alerts and online support etc. You can choose to renew your access to these updates and support on a yearly basis or go over to our industry leading full service platform covering all oncology drug development, 1stOncology.\n<\/p>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/1196672\/cancer_vaccines_analytical_tool?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=jjg8mg&amp;utm_campaign=1719080+-+Cancer+Vaccines+Analytical+Tool+2022%3A+A+Must-have+for+Any+Business+Developer%2C+BI%2FCI+Operative+or+Clinical+Developer+who+Needs+to+be+on+Top+of+this+Hot+and+Fast+Moving+Area+of+Immune-Oncology&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/dsrfu9<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;&#105;l&#x74;&#x6f;&#58;p&#x72;&#x65;&#115;s&#x40;&#x72;&#101;s&#x65;&#x61;&#114;c&#x68;&#x61;&#110;d&#x6d;&#x61;&#114;&#107;e&#x74;&#x73;&#46;c&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#114;e&#x73;&#115;&#64;&#x72;&#101;s&#x65;&#97;r&#x63;&#104;a&#x6e;&#x64;m&#x61;&#x72;&#107;&#x65;&#x74;&#115;&#x2e;&#x63;&#111;m<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Cancer Vaccines: Analytical Tool&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Cancer Vaccines: Analytical Tool is the must have handbook for any business developer, BI\/CI operative or clinical developer who needs to be on top of this hot and fast moving area of immune-oncology. This unique product is truly the only tool of &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/cancer-vaccines-analytical-tool-2022-a-must-have-for-any-business-developer-bi-ci-operative-or-clinical-developer-who-needs-to-be-on-top-of-this-hot-and-fast-moving-area-of-immune-oncology-researc\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45546","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cancer Vaccines Analytical Tool 2022: A Must-have for Any Business Developer, BI\/CI Operative or Clinical Developer who Needs to be on Top of this Hot and Fast Moving Area of Immune-Oncology - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/cancer-vaccines-analytical-tool-2022-a-must-have-for-any-business-developer-bi-ci-operative-or-clinical-developer-who-needs-to-be-on-top-of-this-hot-and-fast-moving-area-of-immune-oncology-researc\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cancer Vaccines Analytical Tool 2022: A Must-have for Any Business Developer, BI\/CI Operative or Clinical Developer who Needs to be on Top of this Hot and Fast Moving Area of Immune-Oncology - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Cancer Vaccines: Analytical Tool&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Cancer Vaccines: Analytical Tool is the must have handbook for any business developer, BI\/CI operative or clinical developer who needs to be on top of this hot and fast moving area of immune-oncology. This unique product is truly the only tool of ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/cancer-vaccines-analytical-tool-2022-a-must-have-for-any-business-developer-bi-ci-operative-or-clinical-developer-who-needs-to-be-on-top-of-this-hot-and-fast-moving-area-of-immune-oncology-researc\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-27T15:02:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220627005557\/en\/1497799\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cancer-vaccines-analytical-tool-2022-a-must-have-for-any-business-developer-bi-ci-operative-or-clinical-developer-who-needs-to-be-on-top-of-this-hot-and-fast-moving-area-of-immune-oncology-researc\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cancer-vaccines-analytical-tool-2022-a-must-have-for-any-business-developer-bi-ci-operative-or-clinical-developer-who-needs-to-be-on-top-of-this-hot-and-fast-moving-area-of-immune-oncology-researc\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Cancer Vaccines Analytical Tool 2022: A Must-have for Any Business Developer, BI\\\/CI Operative or Clinical Developer who Needs to be on Top of this Hot and Fast Moving Area of Immune-Oncology &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-06-27T15:02:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cancer-vaccines-analytical-tool-2022-a-must-have-for-any-business-developer-bi-ci-operative-or-clinical-developer-who-needs-to-be-on-top-of-this-hot-and-fast-moving-area-of-immune-oncology-researc\\\/\"},\"wordCount\":804,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cancer-vaccines-analytical-tool-2022-a-must-have-for-any-business-developer-bi-ci-operative-or-clinical-developer-who-needs-to-be-on-top-of-this-hot-and-fast-moving-area-of-immune-oncology-researc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220627005557\\\/en\\\/1497799\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cancer-vaccines-analytical-tool-2022-a-must-have-for-any-business-developer-bi-ci-operative-or-clinical-developer-who-needs-to-be-on-top-of-this-hot-and-fast-moving-area-of-immune-oncology-researc\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cancer-vaccines-analytical-tool-2022-a-must-have-for-any-business-developer-bi-ci-operative-or-clinical-developer-who-needs-to-be-on-top-of-this-hot-and-fast-moving-area-of-immune-oncology-researc\\\/\",\"name\":\"Cancer Vaccines Analytical Tool 2022: A Must-have for Any Business Developer, BI\\\/CI Operative or Clinical Developer who Needs to be on Top of this Hot and Fast Moving Area of Immune-Oncology - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cancer-vaccines-analytical-tool-2022-a-must-have-for-any-business-developer-bi-ci-operative-or-clinical-developer-who-needs-to-be-on-top-of-this-hot-and-fast-moving-area-of-immune-oncology-researc\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cancer-vaccines-analytical-tool-2022-a-must-have-for-any-business-developer-bi-ci-operative-or-clinical-developer-who-needs-to-be-on-top-of-this-hot-and-fast-moving-area-of-immune-oncology-researc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220627005557\\\/en\\\/1497799\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-06-27T15:02:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cancer-vaccines-analytical-tool-2022-a-must-have-for-any-business-developer-bi-ci-operative-or-clinical-developer-who-needs-to-be-on-top-of-this-hot-and-fast-moving-area-of-immune-oncology-researc\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cancer-vaccines-analytical-tool-2022-a-must-have-for-any-business-developer-bi-ci-operative-or-clinical-developer-who-needs-to-be-on-top-of-this-hot-and-fast-moving-area-of-immune-oncology-researc\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cancer-vaccines-analytical-tool-2022-a-must-have-for-any-business-developer-bi-ci-operative-or-clinical-developer-who-needs-to-be-on-top-of-this-hot-and-fast-moving-area-of-immune-oncology-researc\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220627005557\\\/en\\\/1497799\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220627005557\\\/en\\\/1497799\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cancer-vaccines-analytical-tool-2022-a-must-have-for-any-business-developer-bi-ci-operative-or-clinical-developer-who-needs-to-be-on-top-of-this-hot-and-fast-moving-area-of-immune-oncology-researc\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cancer Vaccines Analytical Tool 2022: A Must-have for Any Business Developer, BI\\\/CI Operative or Clinical Developer who Needs to be on Top of this Hot and Fast Moving Area of Immune-Oncology &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cancer Vaccines Analytical Tool 2022: A Must-have for Any Business Developer, BI\/CI Operative or Clinical Developer who Needs to be on Top of this Hot and Fast Moving Area of Immune-Oncology - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/cancer-vaccines-analytical-tool-2022-a-must-have-for-any-business-developer-bi-ci-operative-or-clinical-developer-who-needs-to-be-on-top-of-this-hot-and-fast-moving-area-of-immune-oncology-researc\/","og_locale":"en_US","og_type":"article","og_title":"Cancer Vaccines Analytical Tool 2022: A Must-have for Any Business Developer, BI\/CI Operative or Clinical Developer who Needs to be on Top of this Hot and Fast Moving Area of Immune-Oncology - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Cancer Vaccines: Analytical Tool&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Cancer Vaccines: Analytical Tool is the must have handbook for any business developer, BI\/CI operative or clinical developer who needs to be on top of this hot and fast moving area of immune-oncology. This unique product is truly the only tool of ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/cancer-vaccines-analytical-tool-2022-a-must-have-for-any-business-developer-bi-ci-operative-or-clinical-developer-who-needs-to-be-on-top-of-this-hot-and-fast-moving-area-of-immune-oncology-researc\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-27T15:02:01+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220627005557\/en\/1497799\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/cancer-vaccines-analytical-tool-2022-a-must-have-for-any-business-developer-bi-ci-operative-or-clinical-developer-who-needs-to-be-on-top-of-this-hot-and-fast-moving-area-of-immune-oncology-researc\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/cancer-vaccines-analytical-tool-2022-a-must-have-for-any-business-developer-bi-ci-operative-or-clinical-developer-who-needs-to-be-on-top-of-this-hot-and-fast-moving-area-of-immune-oncology-researc\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Cancer Vaccines Analytical Tool 2022: A Must-have for Any Business Developer, BI\/CI Operative or Clinical Developer who Needs to be on Top of this Hot and Fast Moving Area of Immune-Oncology &#8211; ResearchAndMarkets.com","datePublished":"2022-06-27T15:02:01+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cancer-vaccines-analytical-tool-2022-a-must-have-for-any-business-developer-bi-ci-operative-or-clinical-developer-who-needs-to-be-on-top-of-this-hot-and-fast-moving-area-of-immune-oncology-researc\/"},"wordCount":804,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cancer-vaccines-analytical-tool-2022-a-must-have-for-any-business-developer-bi-ci-operative-or-clinical-developer-who-needs-to-be-on-top-of-this-hot-and-fast-moving-area-of-immune-oncology-researc\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220627005557\/en\/1497799\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/cancer-vaccines-analytical-tool-2022-a-must-have-for-any-business-developer-bi-ci-operative-or-clinical-developer-who-needs-to-be-on-top-of-this-hot-and-fast-moving-area-of-immune-oncology-researc\/","url":"https:\/\/pharma-trend.com\/en\/cancer-vaccines-analytical-tool-2022-a-must-have-for-any-business-developer-bi-ci-operative-or-clinical-developer-who-needs-to-be-on-top-of-this-hot-and-fast-moving-area-of-immune-oncology-researc\/","name":"Cancer Vaccines Analytical Tool 2022: A Must-have for Any Business Developer, BI\/CI Operative or Clinical Developer who Needs to be on Top of this Hot and Fast Moving Area of Immune-Oncology - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cancer-vaccines-analytical-tool-2022-a-must-have-for-any-business-developer-bi-ci-operative-or-clinical-developer-who-needs-to-be-on-top-of-this-hot-and-fast-moving-area-of-immune-oncology-researc\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cancer-vaccines-analytical-tool-2022-a-must-have-for-any-business-developer-bi-ci-operative-or-clinical-developer-who-needs-to-be-on-top-of-this-hot-and-fast-moving-area-of-immune-oncology-researc\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220627005557\/en\/1497799\/21\/logo.jpg","datePublished":"2022-06-27T15:02:01+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/cancer-vaccines-analytical-tool-2022-a-must-have-for-any-business-developer-bi-ci-operative-or-clinical-developer-who-needs-to-be-on-top-of-this-hot-and-fast-moving-area-of-immune-oncology-researc\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/cancer-vaccines-analytical-tool-2022-a-must-have-for-any-business-developer-bi-ci-operative-or-clinical-developer-who-needs-to-be-on-top-of-this-hot-and-fast-moving-area-of-immune-oncology-researc\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/cancer-vaccines-analytical-tool-2022-a-must-have-for-any-business-developer-bi-ci-operative-or-clinical-developer-who-needs-to-be-on-top-of-this-hot-and-fast-moving-area-of-immune-oncology-researc\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220627005557\/en\/1497799\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220627005557\/en\/1497799\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/cancer-vaccines-analytical-tool-2022-a-must-have-for-any-business-developer-bi-ci-operative-or-clinical-developer-who-needs-to-be-on-top-of-this-hot-and-fast-moving-area-of-immune-oncology-researc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Cancer Vaccines Analytical Tool 2022: A Must-have for Any Business Developer, BI\/CI Operative or Clinical Developer who Needs to be on Top of this Hot and Fast Moving Area of Immune-Oncology &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45546","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45546"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45546\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45546"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45546"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45546"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}